Congenital Disorder Of Glycosylation, Type Ip
CDG1P

Contact us
 
Return to database




Prevalence (%) of clinical parameters based on data from 1 references describing 2 individuals







Add new symptom/sign to this disease

Select symptom from list or write it in the box
Pubmed id number as a reference Organ system affected
Number of patients in the reference Percent affected patients (Between 0 and 1, eg. 0.1 = 10%)
Please provide your name and contact information as a reference
Name Institute Phone number Email address


List of symptoms



Symptom/sign Organ system Percent affected Pubmed id Added on(yyyy-mm-dd) Edit/add reference
Hypotonia nervous 100 % 30676690 2024-06-14
Developmental delay multi 100 % 30676690 2024-06-14
Visual immaturity nervous 50 % 30676690 2024-06-14
Hearing loss nervous 50 % 30676690 2024-06-14
Large ears integumentary 50 % 30676690 2024-06-14
Myopia nervous 50 % 30676690 2024-06-14
Seizures nervous 50 % 30676690 2024-06-14
Microcephaly nervous 50 % 30676690 2024-06-14
Hypertonia nervous 50 % 30676690 2024-06-14
Instability of body temperature multi 50 % 30676690 2024-06-14
Strabismus nervous 50 % 30676690 2024-06-14
Mental retardation nervous 50 % 30676690 2024-06-14
Hypsarrhythmia nervous 50 % 30676690 2024-06-14
Inverted nipples integumentary 50 % 30676690 2024-06-14
Vomiting digestive 50 % 30676690 2024-06-14
Feeding difficulties digestive 50 % 30676690 2024-06-14
Visual impairment nervous 50 % 30676690 2024-06-14
Muscle weakness skeletal 50 % 30676690 2024-06-14



List of references:


ALG11-CDG syndrome: Expanding the phenotype.
Maria K Haanpää, Bobby G Ng, Natalie M Gallant, Kathryn E Singh, Candida Brown, Virginia Kimonis, Hudson H Freeze, Eric A Muller,



American journal of medical genetics. Part A - Mar 2019